COVID-19 News: New variant of Omicron does not kill antibodies, new Lancet study reveals

London: According to a recent study, the BA.2.75.2 form of Omicron is not neutralized by antibodies present in the blood and is also not affected by many COVID-19 antibody related treatments. This study is published in the journal Lancet Infectious Disease. According to the findings of researchers from the Karolinska Institute in Sweden, in the winter season SARS-CoV-2 There is a risk of developing infections from the form unless newly developed vaccines help boost people’s immunity.

Study author Ben Murrell, an assistant professor at the Karolinska Institutet, said antibody immunity is not yet completely eradicated, with BA.2.75.2 showing much greater resistance than previously studied forms. SARS-CoV-2 Virus ‘Spike Protein’ Enters human cells through and infects them.

Also read- XBB, the new variant of Corona spread in these countries, created a stir, know how dangerous it is

According to the study, antibodies present in samples taken from 75 blood donors in Stockholm were only one-sixth as effective in neutralizing BA.2.75.2. These samples were taken at three different times. Some samples were taken in November last year when the Omicron form had not been revealed. Some samples were taken in April and some in late August to early September.

Be the first to read breaking news in Hindi News18 Hindi| Today’s latest news, live news updates, read the most reliable Hindi news website News18 Hindi|

Tags:, corona virus research, COVID 19, Omicron variant